COMMUNIQUÉS West-GlobeNewswire

Eyenovia Announces Conference Call and Webcast for Second Quarter 2018 Financial Results

31/07/2018 - 14:30

NEW YORK, July 31, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]

Profound Medical Announces Term Loan Agreement with CIBC Innovation Banking

31/07/2018 - 14:30

TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSX:PRN) (OTCQX:PRFMF) today announced that it has entered into a term loan agreement (the “Agreement”) with the CIBC [...]

Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1

31/07/2018 - 14:30

Providing more affordable full-length single-cell mRNA sequencing with industry-leading coverage and sensitivity for in-depth cellular characterization SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- [...]

ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation

31/07/2018 - 14:30

Single Phase 3 trial may be sufficient for approval of atrial fibrillation indication Phase 3 clinical trial Special Protocol Assessment submission anticipated 3Q2018 Gencaro is in development as potentially the first [...]

Tower One Receives Master Lease Agreement From Avantel Colombia

31/07/2018 - 14:30

VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE:TO) (OTCQB:TOWTF) (Frankfurt:1P3N) (“Tower One” or the “Company”) announces it has signed a Master Lease Agreement (the ”MLA [...]

European Patent Office to Grant ToolGen, Inc. a patent on CRISPR-Cas9 system for genome editing

31/07/2018 - 14:30

SEOUL, South Korea, July 31, 2018 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX 199800) announced today that on July 26, 2018 the European Patent Office (EPO) issued a Decision to Grant to ToolGen a European patent covering [...]

Novelion Therapeutics Announces Marketing Authorization for MYALEPTA® (metreleptin) in the European Union to Treat Generalized and Partial Lipodystrophy

31/07/2018 - 14:15

MYALEPTA is the first approved therapy in Europe indicated as an adjunct to diet as a replacement therapy to treat the complications of leptin deficiency in lipodystrophy patients VANCOUVER, British Columbia, July 31, [...]

IMV ServiceTrak™ Awards for Clinical Laboratory Instruments Announced Today

31/07/2018 - 14:02

ARLINGTON, Va., July 31, 2018 (GLOBE NEWSWIRE) -- Today, IMV, part of the Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the [...]

Endocyte Provides Second Quarter 2018 Financial Results and Operational Update

31/07/2018 - 14:01

-Initiated phase 3 VISION study of 177 Lu-PSMA-617 in mCRPC- -Secured commercial supply of no-carrier-added Lutetium-177 through 2035 - -Investigational new drug (IND) filing for EC17/CAR T-cell therapy on track for [...]

MediWound to Host Second Quarter 2018 Financial Results Conference Call on August 7 at 8:30 a.m. Eastern Time

31/07/2018 - 14:00

YAVNE, Israel, July 31, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today [...]

Nemaura Initiates US FDA Studies, and Reports Positive Interim Data from Home-Use Portion of Study

31/07/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today announced [...]

Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2018 Financial and Operating Results

31/07/2018 - 14:00

BOTHELL, Wash., July 31, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Kane Biotech and the U.S. Army Institute of Surgical Research Sign Extension of Cooperative Research and Development Agreement

31/07/2018 - 14:00

WINNIPEG, Manitoba, July 31, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce a three year Cooperative Research and Development Agreement [...]

Nu-Med Plus, Inc. Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval

31/07/2018 - 14:00

Innovative Nitric Oxide Delivery Device Company Announces Program to Attain ISO 13485 Certification SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB:NUMD), a medical device leader developing [...]

Histogenics Corporation Appoints E. Lynne Kelley, M.D., FACS As Chief Medical Officer

31/07/2018 - 14:00

Experienced Surgeon and Life Sciences Executive to Lead Medical Affairs, Clinical and Regulatory Operations in Preparation for Potential Commercial Launch of NeoCart® WALTHAM, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- [...]

aTyr Pharma Appoints Jill Broadfoot as Chief Financial Officer

31/07/2018 - 14:00

SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Aptose to Present at the 2018 Global Congress on Oncology and Cancer

31/07/2018 - 14:00

SAN DIEGO and TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]

PolarityTE, Inc. Announces Alain Adam as Vice President of Sales

31/07/2018 - 14:00

SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL) today announced the appointment of Alain Adam as Vice President of Sales. Mr. Adam will lead the company’s continued development of its [...]

Summary of Calendar for Upcoming Proposed Delcath Rights Offering

31/07/2018 - 14:00

The Company’s Directors and Officers Indicate Intent to Participate in the Rights Offering Once Effective NEW YORK, July 31, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology [...]